https://stock.noler.com/us/stock/f-star-therapeutics-inc https://stock.noler.com/us/stock/f-star-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/f-star-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/f-star-therapeutics-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/f-star-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/f-star-therapeutics-inc/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/f-star-therapeutics-inc/acquired-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/f-star-therapeutics-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/f-star-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/amortization https://stock.noler.com/us/stock/f-star-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/f-star-therapeutics-inc/amount-of-regulatory-assistance-received https://stock.noler.com/us/stock/f-star-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/aoci https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/f-star-therapeutics-inc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/f-star-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/f-star-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/f-star-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/f-star-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/f-star-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/f-star-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/f-star-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/f-star-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/f-star-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/f-star-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/f-star-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/contract-with-customer-liability-increase-decrease-for-contract-acquired-in-business-combination https://stock.noler.com/us/stock/f-star-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/f-star-therapeutics-inc/convertible-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/f-star-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-convertible-threshold-trading-days https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/f-star-therapeutics-inc/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-long-term-liability-charges https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-rent-credit https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/f-star-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/f-star-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/f-star-therapeutics-inc/depreciation https://stock.noler.com/us/stock/f-star-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/f-star-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/f-star-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/f-star-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/f-star-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/embedded-derivative-liability-measurement-input https://stock.noler.com/us/stock/f-star-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/eps https://stock.noler.com/us/stock/f-star-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/f-star-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/f-star-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/f-star-therapeutics-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/f-star-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/finite-lived-intangible-assets-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/f-star-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/f-star-therapeutics-inc/form-d-corporate-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/f-star-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-remainder-of-fiscal-year https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-thereafter https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-five-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-four-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-one-year https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-three-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-two-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/f-star-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/goodwill https://stock.noler.com/us/stock/f-star-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/f-star-therapeutics-inc/goodwill-gross https://stock.noler.com/us/stock/f-star-therapeutics-inc/goodwill-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/f-star-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/f-star-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/f-star-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/f-star-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/f-star-therapeutics-inc/income-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/f-star-therapeutics-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/f-star-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/f-star-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/f-star-therapeutics-inc/indefinite-lived-intangible-assets-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/f-star-therapeutics-inc/indefinite-lived-intangible-assets-purchase-accounting-adjustments https://stock.noler.com/us/stock/f-star-therapeutics-inc/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/f-star-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/f-star-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/f-star-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/f-star-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/f-star-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/f-star-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/f-star-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/f-star-therapeutics-inc/investment-income-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/investments-and-cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/f-star-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/f-star-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/liabilities-fair-value-adjustment https://stock.noler.com/us/stock/f-star-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/line-of-credit-facility-commitment-fee-percentage https://stock.noler.com/us/stock/f-star-therapeutics-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/line-of-credit-facility-interest-rate-at-period-end https://stock.noler.com/us/stock/f-star-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/f-star-therapeutics-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/f-star-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/f-star-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/f-star-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-assets-miscellaneous-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/f-star-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/f-star-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/f-star-therapeutics-inc/payments-for-repurchase-of-private-placement https://stock.noler.com/us/stock/f-star-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/f-star-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/f-star-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/f-star-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/f-star-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/f-star-therapeutics-inc/prepaid-rent https://stock.noler.com/us/stock/f-star-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/f-star-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/f-star-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/f-star-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/f-star-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/f-star-therapeutics-inc/public-float https://stock.noler.com/us/stock/f-star-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/f-star-therapeutics-inc/restricted-cash-equivalents-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/f-star-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/f-star-therapeutics-inc/revenue https://stock.noler.com/us/stock/f-star-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/f-star-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/f-star-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/f-star-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-issued-for-options-exercised https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/f-star-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/f-star-therapeutics-inc/short-term-borrowings https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/f-star-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/f-star-therapeutics-inc/sublease-income https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/f-star-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/f-star-therapeutics-inc/total-assets https://stock.noler.com/us/stock/f-star-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/f-star-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/f-star-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/f-star-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/f-star-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/f-star-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/f-star-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/f-star-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/f-star-therapeutics-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/f-star-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/f-star-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted